MacroGenics
MGNX
156 hedge funds and large institutions have $918M invested in MacroGenics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 22 closing their positions.
101% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $613K
1% more funds holding
Funds holding: 154 → 156 (+2)
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
8% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 48
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.35% less ownership
Funds ownership: 94.72% → 93.38% (-1.3%)
24% less capital invested
Capital invested by funds: $1.21B → $918M (-$294M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$50.8M |
| 2 |
Millennium Management
New York
|
+$9.74M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.09M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.05M |
| 5 |
Morgan Stanley
New York
|
+$3.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$41.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.1M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$10.5M |
| 4 |
PA
Perceptive Advisors
New York
|
-$9.09M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.5M |
MGNX Hedge Fund Activity: Q4 2021 in Review
156 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2021, worth a combined $918M — down 24% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new MGNX positions and 22 closed out — a net gain of 2 holders — while 52 added to existing stakes and 48 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $50.8M. The largest seller was Victory Capital Management, exiting entirely with an estimated $41.1M sold.
- 156 institutional investors held MacroGenics (MGNX) as of Q4 2021, up from 154 in Q3 2021.
- Funds reported $918M of MacroGenics stock for Q4 2021, down 24% quarter-over-quarter.
- 24 funds opened new MacroGenics positions in Q4 2021 and 22 closed out, a net change of +2 holders.
- The largest MacroGenics buyer in Q4 2021 was Armistice Capital, an estimated $50.8M added.
- The largest MacroGenics seller in Q4 2021 was Victory Capital Management, an estimated $41.1M sold.
Based on aggregated 13F filings for Q4 2021.